<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
  <head>
    <meta http-equiv="Content-Type" content="text/html; charset=UTF-8" />
    		<meta name="keywords" content="Atomoxetine,Atomoxetine.png,Antidepressants,Antidepressants,ATC code N06,Alaproclate,Amineptine,Amitriptyline,Amoxapine,Anatomical Therapeutic Chemical Classification System,Antidepressant" />
		<link rel="shortcut icon" href="/favicon.ico" />
		<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (English)" />
		<link rel="copyright" href="../../../COPYING.html" />
    <title>Atomoxetine - Wikipedia, the free encyclopedia</title>
    <style type="text/css">/*<![CDATA[*/ @import "../../../skins/htmldump/main.css"; /*]]>*/</style>
    <link rel="stylesheet" type="text/css" media="print" href="../../../skins/common/commonPrint.css" />
    <!--[if lt IE 5.5000]><style type="text/css">@import "../../../skins/monobook/IE50Fixes.css";</style><![endif]-->
    <!--[if IE 5.5000]><style type="text/css">@import "../../../skins/monobook/IE55Fixes.css";</style><![endif]-->
    <!--[if IE 6]><style type="text/css">@import "../../../skins/monobook/IE60Fixes.css";</style><![endif]-->
    <!--[if IE]><script type="text/javascript" src="../../../skins/common/IEFixes.js"></script>
    <meta http-equiv="imagetoolbar" content="no" /><![endif]-->
    <script type="text/javascript" src="../../../skins/common/wikibits.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/md5.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/utf8.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/lookup.js"></script>
    <script type="text/javascript" src="../../../raw/gen.js"></script>        <style type="text/css">/*<![CDATA[*/
@import "../../../raw/MediaWiki%7ECommon.css";
@import "../../../raw/MediaWiki%7EMonobook.css";
@import "../../../raw/gen.css";
/*]]>*/</style>          </head>
  <body
    class="ns-0">
    <div id="globalWrapper">
      <div id="column-content">
	<div id="content">
	  <a name="top" id="contentTop"></a>
	        <h1 class="firstHeading">Atomoxetine</h1>
	  <div id="bodyContent">
	    <h3 id="siteSub">From Wikipedia, the free encyclopedia</h3>
	    <div id="contentSub"></div>
	    	    <div class="usermessage">You have <a href="../../../1/2/7/User_talk%7E127.0.0.1.html" title="User talk:127.0.0.1">new messages</a> (<a href="../../../1/2/7/User_talk%7E127.0.0.1.html" title="User talk:127.0.0.1">last change</a>).</div>	    <!-- start content -->
	    <table id="drugInfoBox" style="float: right; clear: right; margin: 0 0 0.5em 1em; background: #ffffff;" class="toccolours" border="0" cellpadding="1" align="right" width="280">
<tr>
<td align="center" colspan="2">
<div style="font-size:medium; line-height:167%;">Atomoxetine</div>
</td>
</tr>
<tr>
<td colspan="2" bgcolor="#DDDDDD"><b>Systematic (<a href="../../../i/n/t/International_Union_of_Pure_and_Applied_Chemistry_nomenclature_efd4.html" title="International Union of Pure and Applied Chemistry nomenclature">IUPAC</a>) name</b></td>
</tr>
<tr>
<td bgcolor="#EEEEEE" style="text-align: center; vertical-align: top;" colspan="2"><span style="font-size:11px">(3<i>S</i>)-<i>N</i>-methyl-3-(2-methylphenoxy)-3-phenyl-propan-1-amine</span></td>
</tr>
<tr>
<td colspan="2" bgcolor="#DDDDDD"><b>Identifiers</b></td>
</tr>
<tr>
<td bgcolor="#DDEEFF" width="90"><a href="../../../c/a/s/CAS_registry_number_4b20.html" title="CAS registry number">CAS number</a></td>
<td bgcolor="#EEEEEE"><span class="reflink plainlinksneverexpand"><a href="http://www.nlm.nih.gov/cgi/mesh/2006/MB_cgi?term=82248-59-7&amp;rn=1" class="external text" title="http://www.nlm.nih.gov/cgi/mesh/2006/MB_cgi?term=82248-59-7&amp;rn=1" rel="nofollow">82248-59-7</a></span></td>
</tr>
<tr>
<td bgcolor="#DDEEFF"><a href="../../../a/n/a/Anatomical_Therapeutic_Chemical_Classification_System_186e.html" title="Anatomical Therapeutic Chemical Classification System">ATC code</a></td>
<td bgcolor="#EEEEEE"><a href="../../../a/t/c/ATC_code_N06_9c1c.html" title="ATC code N06">N06</a><span class="reflink plainlinksneverexpand"><a href="http://www.whocc.no/atcddd/indexdatabase/index.php?query=N06BA09" class="external text" title="http://www.whocc.no/atcddd/indexdatabase/index.php?query=N06BA09" rel="nofollow">BA09</a></span></td>
</tr>
<tr>
<td bgcolor="#DDEEFF"><a href="../../../p/u/b/PubChem_a50b.html" title="PubChem">PubChem</a></td>
<td bgcolor="#EEEEEE"><span class="reflink plainlinksneverexpand"><a href="http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=54841" class="external text" title="http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=54841" rel="nofollow">54841</a></span></td>
</tr>
<tr>
<td bgcolor="#DDEEFF"><a href="../../../d/r/u/DrugBank_2050.html" title="DrugBank">DrugBank</a></td>
<td bgcolor="#EEEEEE"><span class="reflink plainlinksneverexpand"><a href="http://redpoll.pharmacy.ualberta.ca/drugbank/cgi-bin/getCard.cgi?CARD=APRD00614" class="external text" title="http://redpoll.pharmacy.ualberta.ca/drugbank/cgi-bin/getCard.cgi?CARD=APRD00614" rel="nofollow">APRD00614</a></span></td>
</tr>
<tr>
<td colspan="2" bgcolor="#DDDDDD"><b>Chemical data</b></td>
</tr>
<tr>
<td bgcolor="#DDEEFF"><a href="../../../c/h/e/Chemical_formula.html" title="Chemical formula">Formula</a></td>
<td bgcolor="#EEEEEE"><a href="../../../c/a/r/Carbon.html" title="Carbon"><span style="color: rgb(000,000,000); font-weight: bold;">C</span></a><sub>17</sub><a href="../../../h/y/d/Hydrogen.html" title="Hydrogen"><span style="color: rgb(154,154,154); font-weight: bold;">H</span></a><sub>21</sub><a href="../../../n/i/t/Nitrogen.html" title="Nitrogen"><span style="color: rgb(000,000,255); font-weight: bold;">N</span></a><a href="../../../o/x/y/Oxygen.html" title="Oxygen"><span style="color: rgb(232,070,070); font-weight: bold;">O</span></a><sup>&#160;</sup></td>
</tr>
<tr>
<td bgcolor="#DDEEFF"><a href="../../../m/o/l/Molecular_mass.html" title="Molecular mass">Mol. mass</a></td>
<td bgcolor="#EEEEEE">255.355 g/mol<br />
291.820 g/mol (hydrochloride)</td>
</tr>
<tr>
<td colspan="2" bgcolor="#DDDDDD"><b>Pharmacokinetic data</b></td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="../../../b/i/o/Bioavailability.html" title="Bioavailability">Bioavailability</a></td>
<td bgcolor="#EEEEEE">63 to 94%</td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="../../../p/l/a/Plasma_protein_binding.html" title="Plasma protein binding">Protein binding</a></td>
<td bgcolor="#EEEEEE">98%</td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="../../../d/r/u/Drug_metabolism.html" title="Drug metabolism">Metabolism</a></td>
<td bgcolor="#EEEEEE"><a href="../../../h/e/p/Hepatic.html" title="Hepatic">Hepatic</a>, via <a href="../../../c/y/p/CYP2D6_c73c.html" title="CYP2D6">CYP2D6</a></td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="../../../b/i/o/Biological_half-life.html" title="Biological half-life">Half life</a></td>
<td bgcolor="#EEEEEE">5 hours</td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="../../../e/x/c/Excretion.html" title="Excretion">Excretion</a></td>
<td bgcolor="#EEEEEE"><a href="../../../k/i/d/Kidney.html" title="Kidney">Renal</a> (&gt;80%) and fecal (&lt;17%)</td>
</tr>
<tr>
<td colspan="2" bgcolor="#DDDDDD"><b>Therapeutic considerations</b></td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="../../../p/r/e/Pregnancy_category.html" title="Pregnancy category">Pregnancy cat.</a></td>
<td bgcolor="#EEEEEE">
<p>B3<small>(<a href="../../../a/u/s/Australia.html" title="Australia">AU</a>)</small> C<small>(<a href="../../../u/n/i/United_States_09d4.html" title="United States">US</a>)</small></p>
</td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="../../../r/e/g/Regulation_of_therapeutic_goods.html" title="Regulation of therapeutic goods">Legal status</a></td>
<td bgcolor="#EEEEEE">
<p><a href="../../../p/r/e/Prescription_drug.html" title="Prescription drug">POM</a><small>(<a href="../../../u/n/i/United_Kingdom_5ad7.html" title="United Kingdom">UK</a>)</small> Unscheduled <small>(US)</small></p>
</td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="../../../r/o/u/Route_of_administration.html" title="Route of administration">Routes</a></td>
<td bgcolor="#EEEEEE">Oral (Capsules: 10, 18, 25, 40, 60, 80 and 100 mg)</td>
</tr>
</table>
<p><b>Atomoxetine</b> is the first non-stimulant drug approved for the treatment of <a href="../../../a/t/t/Attention-deficit_hyperactivity_disorder.html" title="Attention-deficit hyperactivity disorder">attention-deficit hyperactivity disorder</a> (ADHD). It is sold in the form of the <a href="../../../h/y/d/Hydrochloride.html" title="Hydrochloride">hydrochloride</a> salt of atomoxetine. It is manufactured and marketed under the brand name <b>Strattera</b><sup>Â®</sup> by <a href="../../../e/l/i/Eli_Lilly_and_Company_7fa7.html" title="Eli Lilly and Company">Eli Lilly and Company</a> as a generic <b>Attentin</b> by Torrent Pharmaceuticals. There is currently no generic available within the United States due to patent restrictions.</p>
<p>Atomoxetine is classified as a <a href="../../../n/o/r/Norepinephrine_reuptake_inhibitor.html" title="Norepinephrine reuptake inhibitor">norepinephrine reuptake inhibitor</a>, and is approved for use in children, adolescents, and adults. However, its efficacy has not been studied in children under six years old. Its advantage over stimulants for the treatment of ADHD is that it has less abuse potential than stimulants, is not scheduled as a controlled substance and has proven in clinical trials to offer 24 hour coverage of symptoms associated with ADHD in adults and children.</p>
<p>Strattera was originally intended to be a new <a href="../../../a/n/t/Antidepressant.html" title="Antidepressant">antidepressant</a> drug; however, in clinical trials, no such benefits could be proven. Since norepinephrine is believed to play a role in ADHD, Strattera was tested and subsequently approved as an ADHD treatment.</p>
<table id="toc" class="toc" summary="Contents">
<tr>
<td>
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1"><a href="#Nomenclature"><span class="tocnumber">1</span> <span class="toctext">Nomenclature</span></a></li>
<li class="toclevel-1"><a href="#Chemistry_and_composition"><span class="tocnumber">2</span> <span class="toctext">Chemistry and composition</span></a></li>
<li class="toclevel-1"><a href="#Side_effects"><span class="tocnumber">3</span> <span class="toctext">Side effects</span></a>
<ul>
<li class="toclevel-2"><a href="#Discontinuation_adverse_effects"><span class="tocnumber">3.1</span> <span class="toctext">Discontinuation adverse effects</span></a></li>
<li class="toclevel-2"><a href="#Psychiatric_reactions"><span class="tocnumber">3.2</span> <span class="toctext">Psychiatric reactions</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#Potential_for_abuse"><span class="tocnumber">4</span> <span class="toctext">Potential for abuse</span></a></li>
<li class="toclevel-1"><a href="#Off-label_uses"><span class="tocnumber">5</span> <span class="toctext">Off-label uses</span></a></li>
<li class="toclevel-1"><a href="#References"><span class="tocnumber">6</span> <span class="toctext">References</span></a></li>
<li class="toclevel-1"><a href="#External_links"><span class="tocnumber">7</span> <span class="toctext">External links</span></a></li>
</ul>
</td>
</tr>
</table>
<p><script type="text/javascript">
//<![CDATA[
 if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } 
//]]>
</script><a name="Nomenclature" id="Nomenclature"></a></p>
<h2><span class="editsection">[<a href="../../../a/t/o/Atomoxetine.html" title="Edit section: Nomenclature">edit</a>]</span> <span class="mw-headline">Nomenclature</span></h2>
<p>Atomoxetine was originally known as "tomoxetine". However, the U.S. <a href="../../../f/o/o/Food_and_Drug_Administration_b75c.html" title="Food and Drug Administration">Food and Drug Administration</a> (FDA) requested the name be changed because, in their opinion, the similarity of "tomoxetine" to "<a href="../../../t/a/m/Tamoxifen.html" title="Tamoxifen">tamoxifen</a>" (a breast cancer drug) could lead to dispensing errors at pharmacies.</p>
<p><a name="Chemistry_and_composition" id="Chemistry_and_composition"></a></p>
<h2><span class="editsection">[<a href="../../../a/t/o/Atomoxetine.html" title="Edit section: Chemistry and composition">edit</a>]</span> <span class="mw-headline">Chemistry and composition</span></h2>
<p>Atomoxetine is designated chemically as (-)-<i>N</i>-methyl-3-phenyl-3-(o-tolyloxy)-propylamine hydrochloride, and has a <a href="../../../m/o/l/Molecular_mass.html" title="Molecular mass">molecular mass</a> of 291.82. It has a <a href="../../../s/o/l/Solubility.html" title="Solubility">solubility</a> of 27.8 mg/mL in water. Atomoxetine is a white solid that exists as a granular powder inside the capsule, along with pregelatinized starch and <a href="../../../d/i/m/Dimethicone.html" title="Dimethicone">dimethicone</a>. The capsule shells contain <a href="../../../g/e/l/Gelatin.html" title="Gelatin">gelatin</a>, <a href="../../../s/o/d/Sodium_lauryl_sulfate.html" title="Sodium lauryl sulfate">sodium lauryl sulfate</a>, FD&amp;C Blue No. 2, synthetic yellow iron oxide, <a href="../../../t/i/t/Titanium_dioxide.html" title="Titanium dioxide">titanium dioxide</a>, <a href="../../../r/e/d/Red_iron_oxide.html" title="Red iron oxide">red iron oxide</a>, edible black ink, and trace amounts of other inactive ingredients.</p>
<p><a name="Side_effects" id="Side_effects"></a></p>
<h2><span class="editsection">[<a href="../../../a/t/o/Atomoxetine.html" title="Edit section: Side effects">edit</a>]</span> <span class="mw-headline">Side effects</span></h2>
<p>The most common side effect in adults is drowsiness. This can be counteracted in some patients by measures as simple as a cup of coffee, or breathing exercises, while others become exhausted after a short while after taking the pills, and can sleep for up to 10+ hours. Some patients tend to feel lightheaded, dizzy, or "buzzed" as a minor side effect along with the drowsiness. To diminish these side effects, which can interfere with daytime work, study, etc., dosing time is sometimes changed to just before bed; as Strattera is long-acting, it does not "wear off" overnight. Mild hallucinations can be experienced under high doses (300mg).</p>
<p>Also very common is digestive discomfort, such as <a href="../../../h/e/a/Heartburn.html" title="Heartburn">heartburn</a>. The most common side effects in children and adolescents (and, after drowsiness, in adults) are upset stomach, nausea, and vomiting. The medication's tendency to decrease appetite may contribute to this problem, as taking Strattera on an empty stomach is usually discouraged; it can also be a problem in itself, in the form of hunger pangs. Consumption of dairy products can cause further upset.</p>
<p>A significant minority of adult male patients taking Strattera suffer minor to severe sexual side effects, including <a href="../../../e/r/e/Erectile_dysfunction.html" title="Erectile dysfunction">erectile dysfunction</a>, <a href="../../../r/e/t/Retrograde_ejaculation.html" title="Retrograde ejaculation">retrograde ejaculation</a>, painful <a href="../../../o/r/g/Orgasm.html" title="Orgasm">orgasm</a>, and the decoupling of orgasm from <a href="../../../e/j/a/Ejaculation.html" title="Ejaculation">ejaculation</a>, wherein ejaculation takes place up to ten seconds before or after orgasm.</p>
<p>Two confirmed cases of liver injury have been reported by <a href="../../../e/l/i/Eli_Lilly_and_Company_7fa7.html" title="Eli Lilly and Company">Eli Lilly and Company</a> out of approximately two million prescriptions written. In both cases upon discontinuation of atomoxetine, patients' liver functions returned to normal.</p>
<p><a name="Discontinuation_adverse_effects" id="Discontinuation_adverse_effects"></a></p>
<h3><span class="editsection">[<a href="../../../a/t/o/Atomoxetine.html" title="Edit section: Discontinuation adverse effects">edit</a>]</span> <span class="mw-headline">Discontinuation adverse effects</span></h3>
<dl>
<dd><i>Further information: <a href="../../../c/h/e/Chemical_synapse.html" title="Chemical synapse">Chemical synapse</a></i></dd>
</dl>
<p>The central nervous system (CNS) adapts to the presence of psychoactive drugs. Such adaptation commonly involves the readjustment of neuroreceptors to compensate for the acute pharmacological action of the medication. This adaptation theory also explains why withdrawal symptoms and signs can occur on the discontinuation of such medications as clearance of drug can occur at a rate faster than the brain can readjust to the absence of medication. Hence, <a href="../../../p/h/a/Pharmacodynamic.html" title="Pharmacodynamic">pharmacodynamic</a> and <a href="../../../p/h/a/Pharmacokinetic.html" title="Pharmacokinetic">pharmacokinetic</a> factors contribute to the risk of a withdrawal syndrome.</p>
<p><a name="Psychiatric_reactions" id="Psychiatric_reactions"></a></p>
<h3><span class="editsection">[<a href="../../../a/t/o/Atomoxetine.html" title="Edit section: Psychiatric reactions">edit</a>]</span> <span class="mw-headline">Psychiatric reactions</span></h3>
<p>In September 2005, Strattera was determined to increase risk of suicidal thoughts among children and adolescents; one attempted suicide and five cases of suicidal thoughts were reported out of 1,357 young patients taking Strattera, while none was reported out of a control group of 851 taking placebos. <a href="http://www.foxnews.com/story/0,2933,170777,00.html" class="external autonumber" title="http://www.foxnews.com/story/0,2933,170777,00.html" rel="nofollow">[1]</a>, <a href="http://sfgate.com/cgi-bin/article.cgi?f=/n/a/2005/09/29/financial/f092936D43.DTL&amp;hw=Strattera&amp;sn=001&amp;sc=1000" class="external autonumber" title="http://sfgate.com/cgi-bin/article.cgi?f=/n/a/2005/09/29/financial/f092936D43.DTL&amp;hw=Strattera&amp;sn=001&amp;sc=1000" rel="nofollow">[2]</a>. The FDA has required that <a href="../../../b/l/a/Black_box_warning.html" title="Black box warning">black box warnings</a> be placed on all antidepressant medications warning they may result in increased risk of suicidal tendencies in children and adolescents; therefore, Strattera bears such a warning.</p>
<p>In less than three years on the market 10,988 adverse "psychiatric reactions" have been reported to Eli Lilly for the ADHD drug Strattera, according to the British Medicines and Healthcare products Regulatory Agency (MHRA), January 2006.</p>
<p><a name="Potential_for_abuse" id="Potential_for_abuse"></a></p>
<h2><span class="editsection">[<a href="../../../a/t/o/Atomoxetine.html" title="Edit section: Potential for abuse">edit</a>]</span> <span class="mw-headline">Potential for abuse</span></h2>
<p>To date, the potential for abuse of Strattera has not been exhaustively researched. The two studies that have been performed suggest that atomoxetine has a low to moderate risk for abuse, since it has a long titration time (meaning that it may have no effect on the user unless they've been taking it regularly for days) and does not produce strong stimulating effects like most other ADHD medications (which are usually <a href="../../../d/o/p/Dopamine_reuptake_inhibitor.html" title="Dopamine reuptake inhibitor">dopamine reuptake inhibitors</a>). Monkeys will not self-administer atomoxetine at the doses tested (Gasior et al, Neuropharm 30:758, 2005; Wee &amp; Woolverton, Drug Alcohol Depend 75:271, 2004). However, rats, pigeons and monkeys trained to distinguish <a href="../../../c/o/c/Cocaine.html" title="Cocaine">cocaine</a> or <a href="../../../m/e/t/Methamphetamine.html" title="Methamphetamine">methamphetamine</a> from saline indicate that atomoxetine produces effects indistinguishable from low doses of cocaine or methamphetamine, but not at all like high doses of cocaine (Spealman, JPET 271:53, 1995; Sasaki et al., Psychopharm 120:303, 1995). No place preference studies have been conducted with atomoxetine.</p>
<p><a name="Off-label_uses" id="Off-label_uses"></a></p>
<h2><span class="editsection">[<a href="../../../a/t/o/Atomoxetine.html" title="Edit section: Off-label uses">edit</a>]</span> <span class="mw-headline">Off-label uses</span></h2>
<p>While depression is most commonly associated with the neurotransmitter <a href="../../../s/e/r/Serotonin.html" title="Serotonin">serotonin</a>, an imbalance of other neurotransmitters may also result in clinical depression. To that end, atomoxetine, which inhibits the reuptake of <a href="../../../n/o/r/Norepinephrine.html" title="Norepinephrine">norepinephrine</a>, was originally explored by Eli Lilly as a treatment for depression, but did not show a benefit to risk ratio in trials. Failed clinical trials are not submitted to drug regulatory agencies and are considered trade secrets. Subsequently, Lilly then chose to pursue an ADHD treatment route for atomoxetine. Many patients have seen a pronounced anti-depressive effect in conjunction with other depressants. More study is needed to understand the full pharmacodynamics.<sup id="_ref-0" class="reference"><a href="#_note-0" title="">[1]</a></sup><sup id="_ref-1" class="reference"><a href="#_note-1" title="">[2]</a></sup><sup id="_ref-2" class="reference"><a href="#_note-2" title="">[3]</a></sup><sup id="_ref-3" class="reference"><a href="#_note-3" title="">[4]</a></sup><sup id="_ref-4" class="reference"><a href="#_note-4" title="">[5]</a></sup></p>
<p><a name="References" id="References"></a></p>
<h2><span class="editsection">[<a href="../../../a/t/o/Atomoxetine.html" title="Edit section: References">edit</a>]</span> <span class="mw-headline">References</span></h2>
<ol class="references">
<li id="_note-0"><b><a href="#_ref-0" title="">^</a></b> <cite style="font-style:normal">"<a href="http://www.webmd.com/content/article/89/100387.htm" class="external text" title="http://www.webmd.com/content/article/89/100387.htm" rel="nofollow">ADHD and Depression</a>".</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=ADHD+and+Depression&amp;rft.aufirst=WebMD&amp;rft_id=http%3A%2F%2Fwww.webmd.com%2Fcontent%2Farticle%2F89%2F100387.htm">&#160;</span></li>
<li id="_note-1"><b><a href="#_ref-1" title="">^</a></b> <cite style="font-style:normal">Biederman J, Spencer TJ (March, 2006). "<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;cmd=Retrieve&amp;dopt=AbstractPlus&amp;list_uids=16649828&amp;query_hl=2&amp;itool=pubmed_docsum" class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;cmd=Retrieve&amp;dopt=AbstractPlus&amp;list_uids=16649828&amp;query_hl=2&amp;itool=pubmed_docsum" rel="nofollow">Atomoxetine and adult attention-deficit/hyperactivity disorder: the effects of comorbidity.</a>".</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Atomoxetine+and+adult+attention-deficit%2Fhyperactivity+disorder%3A+the+effects+of+comorbidity.&amp;rft.date=March%2C+2006&amp;rft.aulast=Biederman+J&amp;rft.aufirst=Spencer+TJ&amp;rft_id=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Fdb%3Dpubmed%26cmd%3DRetrieve%26dopt%3DAbstractPlus%26list_uids%3D16649828%26query_hl%3D2%26itool%3Dpubmed_docsum">&#160;</span></li>
<li id="_note-2"><b><a href="#_ref-2" title="">^</a></b> <cite style="font-style:normal">Adli M, Pilhatsch MK (March, 2006). "<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;cmd=Retrieve&amp;dopt=AbstractPlus&amp;list_uids=16555170&amp;query_hl=2&amp;itool=pubmed_docsum" class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;cmd=Retrieve&amp;dopt=AbstractPlus&amp;list_uids=16555170&amp;query_hl=2&amp;itool=pubmed_docsum" rel="nofollow">Augmentation with atomoxetine in treatment-resistant depression with psychotic features. A case report.</a>".</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Augmentation+with+atomoxetine+in+treatment-resistant+depression+with+psychotic+features.+A+case+report.&amp;rft.date=March%2C+2006&amp;rft.aulast=Adli+M&amp;rft.aufirst=Pilhatsch+MK&amp;rft_id=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Fdb%3Dpubmed%26cmd%3DRetrieve%26dopt%3DAbstractPlus%26list_uids%3D16555170%26query_hl%3D2%26itool%3Dpubmed_docsum">&#160;</span></li>
<li id="_note-3"><b><a href="#_ref-3" title="">^</a></b> <cite style="font-style:normal">Price LH, Carpenter LL (Oct, 2005). "<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;cmd=Retrieve&amp;dopt=AbstractPlus&amp;list_uids=16259536&amp;query_hl=2&amp;itool=pubmed_docsum" class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;cmd=Retrieve&amp;dopt=AbstractPlus&amp;list_uids=16259536&amp;query_hl=2&amp;itool=pubmed_docsum" rel="nofollow">Augmentation with open-label atomoxetine for partial or nonresponse to antidepressants.</a>".</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Augmentation+with+open-label+atomoxetine+for+partial+or+nonresponse+to+antidepressants.&amp;rft.date=Oct%2C+2005&amp;rft.aulast=Price+LH&amp;rft.aufirst=Carpenter+LL&amp;rft_id=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Fdb%3Dpubmed%26cmd%3DRetrieve%26dopt%3DAbstractPlus%26list_uids%3D16259536%26query_hl%3D2%26itool%3Dpubmed_docsum">&#160;</span></li>
<li id="_note-4"><b><a href="#_ref-4" title="">^</a></b> <cite style="font-style:normal">Biederman, J, Kratochvil CJ (Sept, 2005). "<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;cmd=Retrieve&amp;dopt=AbstractPlus&amp;list_uids=16113620&amp;query_hl=2&amp;itool=pubmed_docsum" class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;cmd=Retrieve&amp;dopt=AbstractPlus&amp;list_uids=16113620&amp;query_hl=2&amp;itool=pubmed_docsum" rel="nofollow">Atomoxetine alone or combined with fluoxetine for treating ADHD with comorbid depressive or anxiety symptoms.</a>".</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Atomoxetine+alone+or+combined+with+fluoxetine+for+treating+ADHD+with+comorbid+depressive+or+anxiety+symptoms.&amp;rft.date=Sept%2C+2005&amp;rft.aulast=Biederman%2C+J&amp;rft.aufirst=Kratochvil+CJ&amp;rft_id=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Fdb%3Dpubmed%26cmd%3DRetrieve%26dopt%3DAbstractPlus%26list_uids%3D16113620%26query_hl%3D2%26itool%3Dpubmed_docsum">&#160;</span></li>
</ol>
<p><a name="External_links" id="External_links"></a></p>
<h2><span class="editsection">[<a href="../../../a/t/o/Atomoxetine.html" title="Edit section: External links">edit</a>]</span> <span class="mw-headline">External links</span></h2>
<ul>
<li><a href="http://www.rxlist.com/cgi/generic3/strattera.htm" class="external text" title="http://www.rxlist.com/cgi/generic3/strattera.htm" rel="nofollow">RxList.com - Strattera</a></li>
<li><a href="http://www.strattera.com/1_2_taking_strattera/1_2_5_2_available.jsp" class="external text" title="http://www.strattera.com/1_2_taking_strattera/1_2_5_2_available.jsp" rel="nofollow">Strattera Available Dosages</a></li>
<li><a href="http://medlibrary.org/drugs/other/strattera.html" class="external text" title="http://medlibrary.org/drugs/other/strattera.html" rel="nofollow">Detailed Strattera Consumer Information: Uses, Precautions, Side Effects</a></li>
<li><a href="http://www.lillytrials.com/results/by_product/results_strattera.html" class="external text" title="http://www.lillytrials.com/results/by_product/results_strattera.html" rel="nofollow">All Lilly trials</a></li>
<li><a href="http://www.ehs.lilly.com/msds/msds_atomoxetine_hydrochloride_tablets_and_capsules.html" class="external text" title="http://www.ehs.lilly.com/msds/msds_atomoxetine_hydrochloride_tablets_and_capsules.html" rel="nofollow">MSDS for Atomoxetine HCl</a></li>
<li><a href="http://classwork.busadm.mu.edu/Economics%20Newspaper%20Articles/Microeconomics/Price%20Searching%20Markets/2004/2004%2004%2021%20By%20learning%20from%20failures%20Lilly%20keeps%20drug%20pipeline%20full.PDF" class="external text" title="http://classwork.busadm.mu.edu/Economics%20Newspaper%20Articles/Microeconomics/Price%20Searching%20Markets/2004/2004%2004%2021%20By%20learning%20from%20failures%20Lilly%20keeps%20drug%20pipeline%20full.PDF" rel="nofollow">"By learning from failures, Lilly keeps drug pipeline full", The Wall Street Journal, April 21, 2004</a></li>
</ul>
<p><br /></p>
<table class="navbox collapsible" style="margin: auto; text-align=left">
<tr>
<th colspan="2" style="text-align:center;">
<div class="noprint plainlinksneverexpand" style="background-color:transparent; padding:0; font-weight:normal; font-size:xx-small; color:#000000; white-space:nowrap; float:left;width:6em;text-align:left;"><a href="../../../a/n/t/Template%7EAntidepressants_b6a6.html" title="Template:Antidepressants"><span title="View this template">v</span></a>&#160;<span style="font-size:80%;">â¢</span>&#160;<a href="../../../a/n/t/Template_talk%7EAntidepressants_2d19.html" title="Template talk:Antidepressants"><span title="Discussion about this template">d</span></a>&#160;<span style="font-size:80%;">â¢</span>&#160;<a href="http://en.wikipedia.org../../../a/n/t/Template%7EAntidepressants_b6a6.html" class="external text" title="http://en.wikipedia.org../../../a/n/t/Template%7EAntidepressants_b6a6.html" rel="nofollow"><span style="color: #002bb8;" title="You can edit this template. Please use the preview button before saving.">e</span></a></div>
<a href="../../../a/n/t/Antidepressant.html" title="Antidepressant">Antidepressants</a> (<a href="../../../a/t/c/ATC_code_N06_9c1c.html#N06A_Antidepressants" title="ATC code N06">ATC N06A</a>)</th>
</tr>
<tr>
<th style=""><a href="../../../m/o/n/Monoamine_oxidase_inhibitor.html" title="Monoamine oxidase inhibitor">Monoamine oxidase inhibitors</a> (MAOI)</th>
<td><a href="../../../h/a/r/Harmaline.html" title="Harmaline">Harmaline</a>, <a href="../../../i/p/r/Iproniazid.html" title="Iproniazid">Iproniazid</a>, <a href="../../../i/s/o/Isocarboxazid.html" title="Isocarboxazid">Isocarboxazid</a>, <a href="../../../n/i/a/Nialamide.html" title="Nialamide">Nialamide</a>, <a href="../../../p/a/r/Pargyline.html" title="Pargyline">Pargyline</a>, <a href="../../../p/h/e/Phenelzine.html" title="Phenelzine">Phenelzine</a>, <a href="../../../s/e/l/Selegiline.html" title="Selegiline">Selegiline</a>, <a href="../../../t/o/l/Toloxatone.html" title="Toloxatone">Toloxatone</a>, <a href="../../../t/r/a/Tranylcypromine.html" title="Tranylcypromine">Tranylcypromine</a><br />
<i><a href="../../../r/e/v/Reversible_inhibitor_of_monoamine_oxidase_A_da48.html" title="Reversible inhibitor of monoamine oxidase A">RIMAs</a>:</i> <a href="../../../b/r/o/Brofaromine.html" title="Brofaromine">Brofaromine</a>, <a href="../../../m/o/c/Moclobemide.html" title="Moclobemide">Moclobemide</a></td>
</tr>
<tr>
<th style=""><a href="../../../d/o/p/Dopamine_reuptake_inhibitor.html" title="Dopamine reuptake inhibitor">Dopamine reuptake inhibitor</a> (DARI)</th>
<td><a href="../../../a/m/i/Amineptine.html" title="Amineptine">Amineptine</a>, <a href="../../../p/h/e/Phenmetrazine.html" title="Phenmetrazine">Phenmetrazine</a>, <a href="../../../v/a/n/Vanoxerine.html" title="Vanoxerine">Vanoxerine</a></td>
</tr>
<tr>
<th style=""><a href="../../../n/o/r/Norepinephrine-dopamine_reuptake_inhibitor.html" title="Norepinephrine-dopamine reuptake inhibitor">Norepinephrine-dopamine reuptake inhibitors</a> (NDRI)</th>
<td><a href="../../../b/u/p/Bupropion.html" title="Bupropion">Bupropion</a></td>
</tr>
<tr>
<th style=""><a href="../../../n/o/r/Norepinephrine_reuptake_inhibitor.html" title="Norepinephrine reuptake inhibitor">Norepinephrine reuptake inhibitor</a> (NRI) or (NARI)</th>
<td><strong class="selflink">Atomoxetine</strong>, <a href="../../../m/a/p/Maprotiline.html" title="Maprotiline">Maprotiline</a>, <a href="../../../r/e/b/Reboxetine.html" title="Reboxetine">Reboxetine</a>, <a href="../../../v/i/l/Viloxazine.html" title="Viloxazine">Viloxazine</a></td>
</tr>
<tr>
<th style=""><a href="../../../s/e/r/Serotonin-norepinephrine_reuptake_inhibitor.html" title="Serotonin-norepinephrine reuptake inhibitor">Serotonin-norepinephrine reuptake inhibitor</a> (SNRI)</th>
<td><a href="../../../d/u/l/Duloxetine.html" title="Duloxetine">Duloxetine</a>, <a href="../../../m/i/l/Milnacipran.html" title="Milnacipran">Milnacipran</a>, <a href="../../../n/e/f/Nefazodone.html" title="Nefazodone">Nefazodone</a> , <a href="../../../v/e/n/Venlafaxine.html" title="Venlafaxine">Venlafaxine</a></td>
</tr>
<tr>
<th style=""><a href="../../../s/e/l/Selective_serotonin_reuptake_inhibitor.html" title="Selective serotonin reuptake inhibitor">Selective serotonin reuptake inhibitor</a> (SSRI)</th>
<td><a href="../../../a/l/a/Alaproclate.html" title="Alaproclate">Alaproclate</a>, <a href="../../../c/i/t/Citalopram.html" title="Citalopram">Citalopram</a>, <a href="../../../e/s/c/Escitalopram.html" title="Escitalopram">Escitalopram</a>, <a href="../../../e/t/o/Etoperidone.html" title="Etoperidone">Etoperidone</a>, <a href="../../../f/l/u/Fluoxetine.html" title="Fluoxetine">Fluoxetine</a>, <a href="../../../f/l/u/Fluvoxamine.html" title="Fluvoxamine">Fluvoxamine</a>, <a href="../../../p/a/r/Paroxetine.html" title="Paroxetine">Paroxetine</a>, <a href="../../../s/e/r/Sertraline.html" title="Sertraline">Sertraline</a>, <a href="../../../z/i/m/Zimelidine.html" title="Zimelidine">Zimelidine</a></td>
</tr>
<tr>
<th style=""><a href="../../../s/e/l/Selective_serotonin_reuptake_enhancer.html" title="Selective serotonin reuptake enhancer">Selective serotonin reuptake enhancer</a> (SSRE)</th>
<td><a href="../../../t/i/a/Tianeptine.html" title="Tianeptine">Tianeptine</a></td>
</tr>
<tr>
<th style=""><a href="../../../n/o/r/Noradrenergic_and_specific_serotonergic_antidepressant.html" title="Noradrenergic and specific serotonergic antidepressant">Noradrenergic and specific serotonergic antidepressant</a> (NaSSA)</th>
<td><a href="../../../m/i/r/Mirtazapine.html" title="Mirtazapine">Mirtazapine</a></td>
</tr>
<tr>
<th style=""><a href="../../../t/r/i/Tricyclic_antidepressant.html" title="Tricyclic antidepressant">Tricyclic antidepressants</a> (TCA)</th>
<td><a href="../../../a/m/i/Amitriptyline.html" title="Amitriptyline">Amitriptyline</a>, <a href="../../../a/m/o/Amoxapine.html" title="Amoxapine">Amoxapine</a>, <a href="../../../b/u/t/Butriptyline.html" title="Butriptyline">Butriptyline</a>, <a href="../../../c/l/o/Clomipramine.html" title="Clomipramine">Clomipramine</a>, <a href="../../../d/e/s/Desipramine.html" title="Desipramine">Desipramine</a>, <a href="../../../d/i/b/Dibenzepin.html" title="Dibenzepin">Dibenzepin</a>, <a href="../../../d/o/s/Dosulepin_hydrochloride.html" title="Dosulepin hydrochloride">Dothiepin</a>, <a href="../../../d/o/x/Doxepin.html" title="Doxepin">Doxepin</a>, <a href="../../../i/m/i/Imipramine.html" title="Imipramine">Imipramine</a>, <a href="../../../i/p/r/Iprindole.html" title="Iprindole">Iprindole</a>, <a href="../../../l/o/f/Lofepramine.html" title="Lofepramine">Lofepramine</a>, <a href="../../../m/e/l/Melitracen.html" title="Melitracen">Melitracen</a>, <a href="../../../n/o/r/Nortriptyline.html" title="Nortriptyline">Nortriptyline</a>, <a href="../../../o/p/i/Opipramol.html" title="Opipramol">Opipramol</a>, <a href="../../../p/r/o/Protriptyline.html" title="Protriptyline">Protriptyline</a>, <a href="../../../t/r/i/Trimipramine.html" title="Trimipramine">Trimipramine</a></td>
</tr>
<tr>
<th style=""><a href="../../../t/e/t/Tetracyclic_antidepressant.html" title="Tetracyclic antidepressant">Tetracyclic antidepressants</a></th>
<td><a href="../../../m/a/p/Maprotiline.html" title="Maprotiline">Maprotiline</a>, <a href="../../../m/i/a/Mianserin.html" title="Mianserin">Mianserin</a>, <a href="../../../n/e/f/Nefazodone.html" title="Nefazodone">Nefazodone</a>, <a href="../../../t/r/a/Trazodone.html" title="Trazodone">Trazodone</a></td>
</tr>
</table>

<!-- 
Pre-expand include size: 62364 bytes
Post-expand include size: 25821 bytes
Template argument size: 13294 bytes
Maximum: 2048000 bytes
-->
<div class="printfooter">
Retrieved from "<a href="http://en.wikipedia.org../../../a/t/o/Atomoxetine.html">http://en.wikipedia.org../../../a/t/o/Atomoxetine.html</a>"</div>
	    <div id="catlinks"><p class='catlinks'><a href="../../../c/a/t/Special%7ECategories_101d.html" title="Special:Categories">Categories</a>: <span dir='ltr'><a href="../../../d/r/u/Category%7EDrug_pages_needing_a_structure_drawing_7dbf.html" title="Category:Drug pages needing a structure drawing">Drug pages needing a structure drawing</a></span> | <span dir='ltr'><a href="../../../n/o/r/Category%7ENorepinephrine_reuptake_inhibitors_30c7.html" title="Category:Norepinephrine reuptake inhibitors">Norepinephrine reuptake inhibitors</a></span> | <span dir='ltr'><a href="../../../l/i/l/Category%7ELilly_66b1.html" title="Category:Lilly">Lilly</a></span></p></div>	    <!-- end content -->
	    <div class="visualClear"></div>
	  </div>
	</div>
      </div>
      <div id="column-one">
	<div id="p-cactions" class="portlet">
	  <h5>Views</h5>
	  <ul>
	    <li id="ca-nstab-main"
	       class="selected"	       ><a href="../../../a/t/o/Atomoxetine.html">Article</a></li><li id="ca-talk"
	       	       ><a href="../../../a/t/o/Talk%7EAtomoxetine_8d62.html">Discussion</a></li><li id="ca-current"
	       	       ><a href="http://en.wikipedia.org/wiki/Atomoxetine">Current revision</a></li>	  </ul>
	</div>
	<div class="portlet" id="p-logo">
	  <a style="background-image: url(../../../images/wiki-en.png);"
	    href="../../../index.html"
	    title="Main Page"></a>
	</div>
	<script type="text/javascript"> if (window.isMSIE55) fixalpha(); </script>
		<div class='portlet' id='p-navigation'>
	  <h5>Navigation</h5>
	  <div class='pBody'>
	    <ul>
	    	      <li id="n-Main-page"><a href="../../../index.html">Main page</a></li>
	     	      <li id="n-Contents"><a href="../../../c/o/n/Wikipedia%7EContents_3181.html">Contents</a></li>
	     	      <li id="n-Featured-content"><a href="../../../f/e/a/Wikipedia%7EFeatured_content_24ba.html">Featured content</a></li>
	     	      <li id="n-currentevents"><a href="../../../c/u/r/Portal%7ECurrent_events_bb60.html">Current events</a></li>
	     	    </ul>
	  </div>
	</div>
		<div class='portlet' id='p-interaction'>
	  <h5>interaction</h5>
	  <div class='pBody'>
	    <ul>
	    	      <li id="n-About-Wikipedia"><a href="../../../a/b/o/Wikipedia%7EAbout_8d82.html">About Wikipedia</a></li>
	     	      <li id="n-portal"><a href="../../../c/o/m/Wikipedia%7ECommunity_Portal_6a3c.html">Community portal</a></li>
	     	      <li id="n-contact"><a href="../../../c/o/n/Wikipedia%7EContact_us_afd6.html">Contact us</a></li>
	     	      <li id="n-sitesupport"><a href="http://wikimediafoundation.org/wiki/Fundraising">Make a donation</a></li>
	     	      <li id="n-help"><a href="../../../c/o/n/Help%7EContents_22de.html">Help</a></li>
	     	    </ul>
	  </div>
	</div>
		<div id="p-search" class="portlet">
	  <h5><label for="searchInput">Search</label></h5>
	  <div id="searchBody" class="pBody">
	    <form action="javascript:goToStatic(3)" id="searchform"><div>
	      <input id="searchInput" name="search" type="text"
	        accesskey="f" value="" />
	      <input type='submit' name="go" class="searchButton" id="searchGoButton"
	        value="Go" />
	    </div></form>
	  </div>
	</div>
	<div id="p-lang" class="portlet">
	  <h5>In other languages</h5>
	  <div class="pBody">
	    <ul>
	      	      <li>
	      <a href="../../../../de/a/t/o/Atomoxetin.html">Deutsch</a>
	      </li>
	      	      <li>
	      <a href="../../../../es/a/t/o/Atomoxetina.html">EspaÃ±ol</a>
	      </li>
	      	      <li>
	      <a href="../../../../nl/a/t/o/Atomoxetine.html">Nederlands</a>
	      </li>
	      	      <li>
	      <a href="../../../../no/a/t/o/Atomoksetin.html">âªNorsk (bokmÃ¥l)â¬</a>
	      </li>
	      	    </ul>
	  </div>
	</div>
	      </div><!-- end of the left (by default at least) column -->
      <div class="visualClear"></div>
      <div id="footer">
    <div id="f-poweredbyico"><a href="http://www.mediawiki.org/"><img src="../../../skins/common/images/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" /></a></div>	<div id="f-copyrightico"><a href="http://wikimediafoundation.org/"><img src="../../../images/wikimedia-button.png" border="0" alt="Wikimedia Foundation"/></a></div>	<ul id="f-list">
	  	  	  <li id="f-credits">This page was last modified 22:24, 23 March 2007 by Wikipedia user <a href="../../../r/j/a/User%7ERJASE1_c81d.html" title="User:RJASE1">RJASE1</a>. Based on work by Wikipedia user(s) Neurosoup, <a href="../../../j/h/s/User%7EJhsBot_294a.html" title="User:JhsBot">JhsBot</a>, Chrisvandemore, <a href="../../../d/e/l/User%7EDeli_nk_ed07.html" title="User:Deli nk">Deli nk</a>, <a href="../../../s/e/l/User%7ESelket_adc6.html" title="User:Selket">Selket</a>, <a href="../../../b/e/e/User%7EBeetstra_df14.html" title="User:Beetstra">Beetstra</a>, <a href="../../../g/u/i/User%7EGuiltyspark_4b70.html" title="User:Guiltyspark">Guiltyspark</a>, <a href="../../../b/o/n/User%7EBonadea_ce0a.html" title="User:Bonadea">Bonadea</a>, <a href="../../../w/i/k/User%7EWiki_alf_522c.html" title="User:Wiki alf">Wiki alf</a>, <a href="../../../m/e/r/User%7EMER-C_4926.html" title="User:MER-C">MER-C</a>, <a href="../../../f/r/e/User%7EFreplySpang_52d7.html" title="User:FreplySpang">FreplySpang</a>, <a href="../../../b/u/b/User%7EBubba73_9231.html" title="User:Bubba73">Bubba73</a>, Sdherndon, <a href="../../../y/a/n/User%7EYandman_f6bf.html" title="User:Yandman">Yandman</a>, <a href="../../../r/y/a/User%7ERyan_Delaney_f359.html" title="User:Ryan Delaney">Ryan Delaney</a>, <a href="../../../g/i/n/User%7EGinkgo100_66a1.html" title="User:Ginkgo100">Ginkgo100</a>, <a href="../../../p/r/i/User%7EPrisonnet_e729.html" title="User:Prisonnet">Prisonnet</a>, <a href="../../../t/h/e/User%7EThe_Hokkaido_Crow_7bd1.html" title="User:The Hokkaido Crow">The Hokkaido Crow</a>, <a href="../../../f/v/a/User%7EFvasconcellos_4804.html" title="User:Fvasconcellos">Fvasconcellos</a>, <a href="../../../t/h/i/User%7EThijs%21bot_bdf4.html" title="User:Thijs!bot">Thijs!bot</a>, <a href="../../../g/i/m/User%7EGimboid13_a48f.html" title="User:Gimboid13">Gimboid13</a>, <a href="../../../a/n/t/User%7EAntiVandalBot_aa84.html" title="User:AntiVandalBot">AntiVandalBot</a>, <a href="../../../c/m/d/User%7ECmdrObot_0605.html" title="User:CmdrObot">CmdrObot</a>, <a href="../../../r/i/c/User%7ERichard_Arthur_Norton_%281958-_%29_421a.html" title="User:Richard Arthur Norton (1958- )">Richard Arthur Norton (1958- )</a>, Doc cadence, <a href="../../../a/r/c/User%7EArcadian_5c4b.html" title="User:Arcadian">Arcadian</a>, Bill D, <a href="../../../r/e/b/User%7EReb42_0a93.html" title="User:Reb42">Reb42</a>, Ollie Garkey, <a href="../../../b/l/u/User%7EBluebot_e595.html" title="User:Bluebot">Bluebot</a>, <a href="../../../f/u/z/User%7EFuzzform_a425.html" title="User:Fuzzform">Fuzzform</a>, <a href="../../../f/l/u/User%7EFlubbit_ef04.html" title="User:Flubbit">Flubbit</a>, <a href="../../../h/a/l/User%7EHalloween_jack_8aad.html" title="User:Halloween jack">Halloween jack</a>, Messiah1010, <a href="../../../u/t/h/User%7EUthbrian_6843.html" title="User:Uthbrian">Uthbrian</a>, <a href="../../../j/e/d/User%7EJedOs_0841.html" title="User:JedOs">JedOs</a>, <a href="../../../a/b/c/User%7EABCD_d6a3.html" title="User:ABCD">ABCD</a>, <a href="../../../o/c/t/User%7EOctavio_L_a603.html" title="User:Octavio L">Octavio L</a>, <a href="../../../j/a/m/User%7EJamesMLane_34be.html" title="User:JamesMLane">JamesMLane</a>, <a href="../../../w/a/n/User%7EWanderingHermit_a03e.html" title="User:WanderingHermit">WanderingHermit</a>, <a href="../../../r/m/k/User%7ERmky87_07f5.html" title="User:Rmky87">Rmky87</a>, <a href="../../../j/f/d/User%7EJfdwolff_9ea6.html" title="User:Jfdwolff">Jfdwolff</a>, <a href="../../../s/i/m/User%7ESimonP_1010.html" title="User:SimonP">SimonP</a>, <a href="../../../t/r/i/User%7ETriddle_3664.html" title="User:Triddle">Triddle</a>, <a href="../../../c/e/y/User%7ECeyockey_fb55.html" title="User:Ceyockey">Ceyockey</a>, <a href="../../../x/e/z/User%7EXezbeth_c481.html" title="User:Xezbeth">Xezbeth</a>, <a href="../../../g/r/o/User%7EGround_194a.html" title="User:Ground">Ground</a>, <a href="../../../m/y/k/User%7EMykhal_d2ab.html" title="User:Mykhal">Mykhal</a>, <a href="../../../m/a/n/User%7EMandel_be9b.html" title="User:Mandel">Mandel</a>, <a href="../../../m/i/c/User%7EMichael_Hardy_e932.html" title="User:Michael Hardy">Michael Hardy</a> and <a href="../../../m/a/x/User%7EMaximus_Rex_f7db.html" title="User:Maximus Rex">Maximus Rex</a> and Anonymous user(s) of Wikipedia.</li>	  <li id="f-copyright">All text is available under the terms of the <a class='internal' href="../../../t/e/x/Wikipedia%7EText_of_the_GNU_Free_Documentation_License_702a.html" title="Wikipedia:Text of the GNU Free Documentation License">GNU Free Documentation License</a>. (See <b><a class='internal' href="../../../c/o/p/Wikipedia%7ECopyrights_92c4.html" title="Wikipedia:Copyrights">Copyrights</a></b> for details.) <br /> Wikipedia&reg; is a registered trademark of the <a href="http://www.wikimediafoundation.org">Wikimedia Foundation, Inc</a>., a US-registered <a class='internal' href="../../../5/0/1/501%28c%29.html#501.28c.29.283.29" title="501(c)(3)">501(c)(3)</a> <a href="http://wikimediafoundation.org/wiki/Deductibility_of_donations">tax-deductible</a> <a class='internal' href="../../../n/o/n/Non-profit_organization.html" title="Non-profit organization">nonprofit</a> <a href="../../../c/h/a/Charitable_organization.html" title="Charitable organization">charity</a>.<br /></li>	  <li id="f-about"><a href="../../../a/b/o/Wikipedia%7EAbout_8d82.html" title="Wikipedia:About">About Wikipedia</a></li>	  <li id="f-disclaimer"><a href="../../../g/e/n/Wikipedia%7EGeneral_disclaimer_3e44.html" title="Wikipedia:General disclaimer">Disclaimers</a></li>	  	</ul>
      </div>
    </div>
  </body>
</html>
